Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Oberbauer

Showing results (231-240 of 291) with videos related to

Pageof 30
Sort By:
Clinical Transplantation|May 10, 2007
Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five yearsChristophe Legendre, Yves Brault, José M Morales, et al.
Frontiers in Medicine|October 27, 2022
Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trialAndreas Heinzel, Eva Schrezenmeier, Florina Regele, et al.
The Journal of Investigative Dermatology|October 31, 2002
Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well toleratedKlemens Rappersberger, Michael Komar, Marie-Eve Ebelin, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Allograft Function as Endpoint for Clinical Trials in Kidney TransplantationLuuk Hilbrands, Klemens Budde, Maria Irene Bellini, et al.
Artificial Organs|July 6, 2016
Introducing The Wiley Transplant Peer Review NetworkAllan D Kirk, Paul S Malchesky, Ron Shapiro, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Alloimmune Risk Stratification for Kidney Transplant RejectionOriol Bestard, Olivier Thaunat, Maria Irene Bellini, et al.
Frontiers in Medicine|August 8, 2022
Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled TrialAndreas Heinzel, Eva Schrezenmeier, Florina Regele, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 2019
Standard work-up of the low-risk kidney transplant candidate: a European expert survey of the ERA-EDTA Developing Education Science and Care for Renal Transplantation in European States Working GroupUmberto Maggiore, Daniel Abramowicz, Klemens Budde, et al.
ESC Heart Failure|April 12, 2026
Design, rationale, and baseline characteristics of the dapagliflozin in hemodialysis (DAPA-HD) trialThomas A Zelniker, Christopher Paschen, Christopher Mann, et al.
Frontiers in Immunology|September 21, 2023
Prospective assessment of pre-existing and <i>de novo</i> anti-HLA IgE in kidney, liver, lung and heart transplantationJasmin Mucha, Ara Cho, Anna Marianne Weijler, et al.
Pageof 30

Showing results (231-240 of 291) with videos related to

Sort By:
Pageof 30
Clinical Transplantation|May 10, 2007
Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five yearsChristophe Legendre, Yves Brault, José M Morales, et al.
Frontiers in Medicine|October 27, 2022
Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trialAndreas Heinzel, Eva Schrezenmeier, Florina Regele, et al.
The Journal of Investigative Dermatology|October 31, 2002
Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well toleratedKlemens Rappersberger, Michael Komar, Marie-Eve Ebelin, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Allograft Function as Endpoint for Clinical Trials in Kidney TransplantationLuuk Hilbrands, Klemens Budde, Maria Irene Bellini, et al.
Artificial Organs|July 6, 2016
Introducing The Wiley Transplant Peer Review NetworkAllan D Kirk, Paul S Malchesky, Ron Shapiro, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Alloimmune Risk Stratification for Kidney Transplant RejectionOriol Bestard, Olivier Thaunat, Maria Irene Bellini, et al.
Frontiers in Medicine|August 8, 2022
Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled TrialAndreas Heinzel, Eva Schrezenmeier, Florina Regele, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 2019
Standard work-up of the low-risk kidney transplant candidate: a European expert survey of the ERA-EDTA Developing Education Science and Care for Renal Transplantation in European States Working GroupUmberto Maggiore, Daniel Abramowicz, Klemens Budde, et al.
ESC Heart Failure|April 12, 2026
Design, rationale, and baseline characteristics of the dapagliflozin in hemodialysis (DAPA-HD) trialThomas A Zelniker, Christopher Paschen, Christopher Mann, et al.
Frontiers in Immunology|September 21, 2023
Prospective assessment of pre-existing and <i>de novo</i> anti-HLA IgE in kidney, liver, lung and heart transplantationJasmin Mucha, Ara Cho, Anna Marianne Weijler, et al.
Pageof 30